Fort Washington Investment Advisors Inc Biogen Inc. Transaction History
Fort Washington Investment Advisors Inc
- $15 Billion
- Q2 2024
A detailed history of Fort Washington Investment Advisors Inc transactions in Biogen Inc. stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 17,814 shares of BIIB stock, worth $3.48 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,814
Previous 17,814
-0.0%
Holding current value
$3.48 Million
Previous $3.84 Million
7.5%
% of portfolio
0.03%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.25 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.2 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.84 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.39 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.11 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $28.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...